Van Bruggen; Nicholas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Bruggen; Nicholas.The latest application filed is for "il-22 polypeptides and il-22 fc fusion proteins and methods of use".

Company Profile

7.5.19

Van Bruggen; Nicholas - San Carlos CA
Van Bruggen; Nicholas - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins Grant 11,136,365 - Scheer , et al. October 5, 2	2021-10-05
Pharmaceutical compositions of IL-22 Fc fusion proteins Grant 10,584,155 - Scheer , et al.	2020-03-10
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190233491 - Scheer; Justin ; et al.	2019-08-01
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177386 - SCHEER; Justin ; et al.	2019-06-13
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177387 - Scheer; Justin ; et al.	2019-06-13
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177389 - SCHEER; Justin ; et al.	2019-06-13
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177390 - Scheer; Justin ; et al.	2019-06-13
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177388 - SCHEER; Justin ; et al.	2019-06-13
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20180362608 - SCHEER; Justin ; et al.	2018-12-20
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170320926 - SCHEER; Justin ; et al.	2017-11-09
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170088596 - SCHEER; Justin ; et al.	2017-03-30
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170008942 - SCHEER; Justin ; et al.	2017-01-12
Vascular Endothelial Cell Growth Factor Antagonists And Uses Thereof App 20140363432 - Van Bruggen; Nicholas ; et al.	2014-12-11
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20140314711 - SCHEER; JUSTIN ; et al.	2014-10-23
Vascular endothelial cell growth factor antagonists and uses thereof Grant 8,287,873 - Van Bruggen , et al. October 16, 2	2012-10-16
Vascular Endothelial Cell Growth Factor Antagonists And Uses Thereof App 20120237514 - Van Bruggen; Nicholas ; et al.	2012-09-20
Vascular endothelial cell growth factor antagonists and uses thereof Grant 8,007,799 - Van Bruggen , et al. August 30, 2	2011-08-30
Vascular endothelial cell growth factor antagonists and uses thereof Grant 7,998,931 - Van Bruggen , et al. August 16, 2	2011-08-16
Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-cancer Agent App 20110064670 - Gogineni; Alvin ; et al.	2011-03-17
Vascular Endothelial Cell Growth Factor Antagonists And Uses Thereof App 20080311118 - Van Bruggen; Nicholas ; et al.	2008-12-18
Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof App 20080299116 - Van Bruggen; Nicholas ; et al.	2008-12-04
Vascular Endothelial Cell Growth Factor Antagonists And Uses Thereof App 20070258980 - VAN BRUGGEN; NICHOLAS ; et al.	2007-11-08
Vascular endothelial cell growth factor antagonists and uses thereof App 20050244405 - Van Bruggen, Nicholas ; et al.	2005-11-03
Vascular endothelial cell growth factor antagonists and uses thereof App 20050053599 - Van Bruggen, Nicholas ; et al.	2005-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.